Additionally, the frequency of nTregs was increased and the frequency of pDCs was decreased in the liver with MC38 tumor cells (Supplemental Figure 4, A and D); however, anti-FGL1 mAb treatment did not alter the frequencies or numbers of Tregs (Supplemental Figure 4, B and C) and pDCs (Supplemental Figure 4, E and F) in the liver. This evidence concerns the gene FGL1 and neoplasm.